Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria

References

• Lu CH, Chang WN, Chuang YC, Chang HW. Gram-negative bacillary meningitis in adult post-neurosurgical patients. Surg Neurol 1999;52(5):438-43
   PubMedGoogle Scholar
• Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother 2007;60(1):197-9
   PubMed Web of Science ®Google Scholar
• Kim BN, Peleg AY, Lodise TP, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009;9(4):245-55
   PubMed Web of Science ®Google Scholar
• Moon C, Kwak YG, Kim BN, et al. Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii. J Infect Chemother 2013;19(5):916-19
   PubMed Web of Science ®Google Scholar
• Duncan IB. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymixin B. Antimicrob Agents Chemother 1974;5(1):9-15
   PubMed Web of Science ®Google Scholar
• Barnett M, Bushby SR, Wilkinson S. Sodium sulphomethyl derivatives of polymyxins. Br J Pharmacol 1964;23:552-74
   PubMed Web of Science ®Google Scholar
• Bergen PJ, Li J, Rayner CR, et al. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006;50(6):1953-8
   PubMed Web of Science ®Google Scholar
• Li J, Turnidge J, Milne R, et al. In vitro pharmacodynamic properties of colistin and colistin methanesulphonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2001;45(3):781-5
   PubMed Web of Science ®Google Scholar
• Li J, Milne RW, Nation RL, et al. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001;761(2):167-75
   PubMed Web of Science ®Google Scholar
• Li J, Milne RW, Nation RL, et al. Simple method for assaying colistin methanesulphonate in plasma and urine using high-performance liquid chromatography. Antimicrob Agents Chemother 2002;46(10):3304-7
   PubMed Web of Science ®Google Scholar
• Gobin P, Lemaître F, Marchand S, et al. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry. Antimicrob Agents Chemother 2010;54(5):1941-8
   PubMed Web of Science ®Google Scholar
• Goodwin NJ. Colistin sulfate versus sodium colistimethate. Ann Intern Med 1969;70(1):232-3
   PubMed Web of Science ®Google Scholar
• Jin L, Li J, Nation RL, Nicolazzo JA. Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique. Antimicrob Agents Chemother 2009;53(10):4247-51
   PubMed Web of Science ®Google Scholar
• Jin L, Li J, Nation RL, Nicolazzo JA. Impact of P-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice. Antimicrob Agents Chemother 2011;55(2):502-7
   PubMed Web of Science ®Google Scholar
• Pachón-Ibáñez ME, Docobo-Pérez F, López-Rojas R, et al. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2010;54(3):1165-72
   PubMed Web of Science ®Google Scholar
• Markantonis SL, Markou N, Fousteri M, et al. Penetration of colistin into cerebrospinal fluid. Antimicrob Agents Chemother 2009;53(11):4907-10
   PubMed Web of Science ®Google Scholar
• Antachopoulos C, Karvanen M, Iosifidis E, et al. Serum and cerebrospinal fluid levels of colistin in pediatric patients. Antimicrob Agents Chemother 2010;54(9):3985-7
   PubMed Web of Science ®Google Scholar
• Ziaka M, Markantonis SL, Fousteri M, et al. Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother 2013;57(4):1938-40
   PubMed Web of Science ®Google Scholar
• Shen S, Zhang W. ABC transporters and drug efflux at the blood-brain barrier. Rev Neurosci 2010;21(1):29-53
   PubMed Web of Science ®Google Scholar
• Imberti R, Cusato M, Accetta G, et al. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrob Agents Chemother 2012;56(8):4416-21
   PubMed Web of Science ®Google Scholar
• Plachouras D, Karvanen M, Friberg LE, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother 2009;53(8):3430-6
   PubMed Web of Science ®Google Scholar
• Hoefnagel D, Dammers R, Ter Laak-Poort MP, Avezaat CJ. Risk factors for infections related to external ventricular drainage. Acta Neurochir 2008;150(3):209-14
   PubMed Web of Science ®Google Scholar
• McCracken GH Jr, Mize SG, Threlkeld N. Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet 1980;1(8172):787-91
   PubMed Web of Science ®Google Scholar
• Mustafa MM, Mertsola J, Ramilo O, et al. Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis 1989;160(5):891-5
   PubMed Web of Science ®Google Scholar
• Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007;29(1):9-25
   PubMed Web of Science ®Google Scholar
• Ng J, Gosbell IB, Kelly JA, et al. Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review. J Antimicrob Chemother 2006;58(5):1078-81
   PubMed Web of Science ®Google Scholar
• Khawcharoenporn T, Apisarnthanarak A, Mundy LM. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review. Clin Microbiol Infect 2010;16(7):888-94
   PubMed Web of Science ®Google Scholar
• Katragkou A, Roilides E. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin. J Clin Microbiol 2005;43(9):4916-17
   PubMed Web of Science ®Google Scholar
• Wang JH, Lin PC, Chou CH, et al. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect 2012. [Epub ahead of print]
   Google Scholar
• Alaoui SY, Nejmi SE, Chakir AA, et al. Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumannii. Ann Fr Anesth Reanim 2011;30(11):854-5
   PubMedGoogle Scholar
• Baiocchi M, Catena V, Zago S, et al. Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after neurosurgical ventriculitis. Infez Med 2010;18(3):182-6
   PubMedGoogle Scholar
• Cascio A, Conti A, Sinardi L, et al. Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis 2010;14(7):e572-9
   PubMed Web of Science ®Google Scholar
• Dalgic N, Ceylan Y, Sancar M, et al. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin. Ann Trop Paediatr 2009;29(2):141-7
   PubMed Web of Science ®Google Scholar
• López-Alvarez B, Martín-Láez R, Fariñas MC, et al. Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin. Acta Neurochir 2009;151(11):1465-72
   PubMed Web of Science ®Google Scholar
• Ho YH, Wang LS, Chao HJ, et al. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin. J Microbiol Immunol Infect 2007;40(6):537-40
   PubMedGoogle Scholar
• Yagmur R, Esen F. Intrathecal colistin for treatment of Pseudomonas aeruginosa ventriculitis: report of a case with successful outcome. Crit Care 2006;10(6):428
   PubMed Web of Science ®Google Scholar
• Paramythiotou E, Karakitsos D, Aggelopoulou H, et al. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med Mal Infect 2007;37(2):124-5
   PubMed Web of Science ®Google Scholar
• Al Shirawi N, Memish ZA, Cherfan A, Al Shimemeri A. Post-neurosurgical meningitis due to multidrug-resistant Acinetobacter baumannii treated with intrathecal colistin: case report and review of the literature. J Chemother 2006;18(5):554-8
   PubMed Web of Science ®Google Scholar
• Motaouakkil S, Charra B, Hachimi A, et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect 2006;53(4):274-8
   PubMed Web of Science ®Google Scholar
• Karakitsos D, Paramythiotou E, Samonis G, Karabinis A. Is intraventricular colistin an effective and safe treatment for post-surgical ventriculitis in the intensive care unit? Acta Anaesthesiol Scand 2006;50(10):1309-10
   PubMed Web of Science ®Google Scholar
• Rodríguez Guardado A, Blanco A, Asensi V, et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 2008;61(4):908-13
   PubMed Web of Science ®Google Scholar
• Kim K, Kang HS, Sohn CH, Oh BM. Cauda equina syndrome misdiagnosed as aggravated hydrocephalus: neurological complication of intrathecal colistin in post-surgical meningitis. Acta Neurochir 2011;153(2):425-7
   PubMed Web of Science ®Google Scholar
• Lee CH, Tang YF, Su LH, et al. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Microb Drug Resist 2008;14(3):233-7
   PubMed Web of Science ®Google Scholar
• De Pascale G, Pompucci A, Maviglia R, et al. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin. Minerva Anestesiol 2010;76(11):957-60
   PubMed Web of Science ®Google Scholar
• Enfanto CM, Shin S. Treatment with intrathecal colistin of a resistant extended-spectrum B-lactamase producing Klebsiella pneumoniae in the cerebrospinal fluid. Infect Dis Clin Pract 2007;15(4):274-7
   Google Scholar
• Sahin SH, Selik A, Memis D. Intrathecal colistin for treatment of Acinetobacter spp. meningitis: case report. Internet J Infect Dis 2008;6:2
   Google Scholar
• Ozdemir H, Tapisiz A, Ciftçi E, et al. Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis. Infection 2010;38(3):241-4
   PubMed Web of Science ®Google Scholar
• Hernan RC, Bombicino K, Granados G, et al. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin. Diagn Microbiol Infect Dis 2009;65(2):188-91
   PubMed Web of Science ®Google Scholar
• Iosifidis E, Antachopoulos C, Ioannidou M, et al. Colistin administration to pediatric and neonatal patients. Eur J Pediatr 2010;169(7):867-74
   PubMed Web of Science ®Google Scholar
• Karaiskos I, Galani L, Baziaka F, et al. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Int J Antimicrob Agents 2013;41(5):480-3
   PubMed Web of Science ®Google Scholar
• Schina M, Spyridi E, Daoudakis M, et al. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin. Int J Infect Dis 2006;10(2):178-9
   PubMed Web of Science ®Google Scholar
• Karagoz G, Kadanali A, Dede B, et al. Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin. Int J Antimicrob Agents 2014;43(1):93-4
   PubMed Web of Science ®Google Scholar
• Swift PN, Bushby SR. Haemophilus influenza meningitis treated with polymyxin. Lancet 1951;2(6675):183-90
   PubMed Web of Science ®Google Scholar
• Price DJ, Sleigh JD. Klebsiella meningitis – report of nine cases. J Neurol Neurosurg Psychiatry 1972;35(6):903-8
   PubMed Web of Science ®Google Scholar
• Sueke H, Marsh H, Dhital A. Using intrathecal colistin for multidrug resistant shunt infection. Br J Neurosurg 2005;19(1):51-2
   PubMed Web of Science ®Google Scholar
• Karaiskos I, Galani L, Baziaka F, Giamarellou H. Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Int J Antimicrob Agents 2013;41(6):499-508
   PubMed Web of Science ®Google Scholar
• Rifkind D, Palmer JD. Neutralization of endotoxin toxicity in chick embryos by antibiotics. J Bacteriol 1966;92(4):815-19
   PubMed Web of Science ®Google Scholar
• Aoki N, Tateda K, Kikuchi Y, et al. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 2009;63(3):534-42
   PubMed Web of Science ®Google Scholar
• Warren HS, Kania SA, Siber GR. Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide. Antimicrob Agents Chemother 1985;28(1):107-12
   PubMed Web of Science ®Google Scholar
• Rogers MJ, Cohen J. Comparison of the binding of gram-negative bacterial endotoxin by polymyxin B sulphate, colistin sulphate and colistin sulphomethate sodium. Infection 1986;14(2):79-81
   PubMed Web of Science ®Google Scholar
• Nanjo Y, Ishii Y, Kimura S, et al. Effects of slow-releasing colistin microspheres on endotoxin-induced sepsis. J Infect Chemother 2013;19(4):683-90
   PubMed Web of Science ®Google Scholar
• Cirioni O, Ghiselli R, Orlando F, et al. Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. Crit Care Med 2007;35(7):1717-23
   PubMed Web of Science ®Google Scholar
• Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 2003;4(5):376-85
   PubMed Web of Science ®Google Scholar
• Mertsola J, Ramilo O, Mustafa MM, et al. Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis. Pediatr Infect Dis J 1989;8(12):904-6
   PubMedGoogle Scholar
• de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347(20):1549-56
   PubMed Web of Science ®Google Scholar
• Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2013;6:CD004405
   PubMedGoogle Scholar
• Kaiser AB, McGee ZA. Aminoglycoside therapy of gram-negative bacillary meningitis. N Engl J Med 1975;293(24):1215-20
   PubMed Web of Science ®Google Scholar
• Klastersky J, Mombelli G, Coppens L, et al. Post neurosurgery Gram-negative bacillary meningitis. J Infect 1981;3(Suppl):45-51
   PubMed Web of Science ®Google Scholar
• Gutiérrez-González R, Boto GR, Pérez-Zamarrón A. Cerebrospinal fluid diversion devices and infection. A comprehensive review. Eur J Clin Microbiol Infect Dis 2012;31(6):889-97
   PubMed Web of Science ®Google Scholar
• Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol 2008;255(11):1617-24
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39(9):1267-84
   PubMed Web of Science ®Google Scholar
• Nation RL, Li J, Cars O, et al. Consistent global approach on reporting of colistin doses to promote safe and effective use. Clin Infect Dis 2014;58(1):139-41
   PubMed Web of Science ®Google Scholar